Biochemistry and Action of Clavulanic Acid
- 1 January 1982
- journal article
- Published by SAGE Publications in Scottish Medical Journal
- Vol. 27 (1_suppl) , S10-S16
- https://doi.org/10.1177/00369330820270s103
Abstract
The destruction of amoxycillin by β-lactamase action represents an important mechanism of bacterial resistance to the drug. Data is presented to illustrate that clavulanic acid used in the form of its potassium salt inhibits the amoxycillin destroying action of many different types of β-lactamase for example: the staphylococcal enzyme, the clinically important plasmid mediated enzymes of the TEM, SHV, OXA and PSE types and the chromosomally controlled enzymes produced by Proteus mirabilis and Klebsiella pneumoniae. The mechanisms by which clavulanic acid inhibits β-lactamases and potentiates the antibacterial action of amoxycillin are discussed.Keywords
This publication has 5 references indexed in Scilit:
- beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acidAntimicrobial Agents and Chemotherapy, 1982
- ‘β-Lactams’ as β-lactamase inhibitorsPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1980
- Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerusAntimicrobial Agents and Chemotherapy, 1977
- The β-lactamases of Gram-negative bacteria and their rôle in resistance to β-lactam antibioticsJournal of Antimicrobial Chemotherapy, 1976
- Clavulanic acid, a novel β-lactam isolated from Streptomyces clavuligerus; X-ray crystal structure analysisJournal of the Chemical Society, Chemical Communications, 1976